FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
The company said it would apply in coming months for U.S. regulatory approval. Source link
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...
Sanofi SA and GlaxoSmithKline PLC said they would seek authorization for their Covid-19 vaccine, a sign that pharmaceutical companies still...
Unilever UL 8.58% PLC plans to cut thousands of jobs as part of a reorganization aimed at speeding up its...
Unilever UL 7.73% PLC said it wouldn’t increase its $68 billion offer for GlaxoSmithKline GSK -2.41% PLC’s consumer-healthcare business, effectively...
LONDON— Unilever UL 1.14% PLC said it had approached GlaxoSmithKline GSK 0.91% PLC and Pfizer Inc. PFE -1.06% about an...
A Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. was effective against the Omicron variant in early...
Shares in Germany’s CureVac CVAC -3.47% NV fell by almost half in premarket trading, pointing to hefty losses for investors...
A pair of experimental Covid-19 treatments produced positive results in clinical trials, the companies developing the drugs said Monday. Humanigen...